MICHAEL OBIEFUNE: Open Payments
NPI 1073552881 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$21,329 in 60 payments from 4 companies in 2025. Trend: 2023 $73,038 · 2024 $29,230 · 2025 $21,329
Speaker / faculty: $16,900Food & beverage: $2,339Travel & lodging: $2,090
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 40 | $20,784 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $331 |
| Gilead Sciences, Inc. | 9 | $198 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: CABENUVA, APRETUDE, DOVATO, JARDIANCE, Descovy, RUKOBIA.
Industry payments across MD — which companies pay providers there.
